newsfilter
← Latest News
PR Newswire·

Poseida Therapeutics Announces Strategic Investment by Astellas and Provides Business Update

$50 million strategic investment validates Poseida's proprietary technology and cell therapy approach and supports strategic and operational plans Implementing enhancements to ongoing allogeneic programs based upon